156 related articles for article (PubMed ID: 24120718)
1. No clinically relevant interaction between sugammadex and aspirin on platelet aggregation and coagulation parameters.
de Kam PJ; El Galta R; Kruithof AC; Fennema H; van Lierop MJ; Mihara K; Burggraaf J; Moerland M; Peeters P; Troyer MD
Int J Clin Pharmacol Ther; 2013 Dec; 51(12):976-85. PubMed ID: 24120718
[TBL] [Abstract][Full Text] [Related]
2. Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects.
De Kam PJ; Kruithof AC; van Lierop MJ; Moerland M; Dennie J; Troyer MD; Langdon RB; Gutstein DE; Burggraaf J; El Galta R
Int J Clin Pharmacol Ther; 2014 Aug; 52(8):631-41. PubMed ID: 24800921
[TBL] [Abstract][Full Text] [Related]
3. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
De Kam PJ; Grobara P; Prohn M; Höppener F; Kluft C; Burggraaf J; Langdon RB; Peeters P
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):227-36. PubMed ID: 24447651
[TBL] [Abstract][Full Text] [Related]
4. Interaction potential and tolerability of the coadministration of cilostazol and aspirin.
Mallikaarjun S; Forbes WP; Bramer SL
Clin Pharmacokinet; 1999; 37 Suppl 2():87-93. PubMed ID: 10702891
[TBL] [Abstract][Full Text] [Related]
5. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
7. A PK-PD model-based assessment of sugammadex effects on coagulation parameters.
Bosch R; van Lierop MJ; de Kam PJ; Kruithof AC; Burggraaf J; de Greef R; Visser SA; Johnson-Levonas AO; Kleijn HJ
Eur J Pharm Sci; 2016 Mar; 84():9-17. PubMed ID: 26747019
[TBL] [Abstract][Full Text] [Related]
8. Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?
Wolf HR
Drugs R D; 2006; 7(3):163-72. PubMed ID: 16752942
[TBL] [Abstract][Full Text] [Related]
9. Effect of reversal of neuromuscular blockade with sugammadex versus usual care on bleeding risk in a randomized study of surgical patients.
Rahe-Meyer N; Fennema H; Schulman S; Klimscha W; Przemeck M; Blobner M; Wulf H; Speek M; McCrary Sisk C; Williams-Herman D; Woo T; Szegedi A
Anesthesiology; 2014 Nov; 121(5):969-77. PubMed ID: 25208233
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo- controlled study on the anti-haemostatic effects of Curcuma longa, Angelica sinensis and Panax ginseng.
Fung FY; Wong WH; Ang SK; Koh HL; Kun MC; Lee LH; Li X; Ng HJ; Tan CW; Zhao Y; Linn YC
Phytomedicine; 2017 Aug; 32():88-96. PubMed ID: 28732813
[TBL] [Abstract][Full Text] [Related]
11. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
12. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
[TBL] [Abstract][Full Text] [Related]
13. Aspirin at very ultra low dosage in healthy volunteers: effects on bleeding time, platelet aggregation and coagulation.
Doutremepuich C; de Sèze O; Le Roy D; Lalanne MC; Anne MC
Haemostasis; 1990; 20(2):99-105. PubMed ID: 2347518
[TBL] [Abstract][Full Text] [Related]
14. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam and bleeding disorders.
Boon P; Hulhoven R; Offner F
Acta Neurol Belg; 2007 Dec; 107(4):97-102. PubMed ID: 18416281
[TBL] [Abstract][Full Text] [Related]
16. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
[TBL] [Abstract][Full Text] [Related]
17. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans.
Samra SK; Harrison RL; Bee DE; Valero V
Ann Clin Lab Sci; 1991; 21(5):315-27. PubMed ID: 1952780
[TBL] [Abstract][Full Text] [Related]
18. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test.
Kim JS; Lee KS; Kim YI; Tamai Y; Nakahata R; Takami H
J Clin Neurosci; 2004 Aug; 11(6):600-2. PubMed ID: 15261228
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
20. Effect of Aspirin Supplementation on Hemostatic Responses in Firefighters Aged 40 to 60 Years.
Smith DL; Horn GP; Woods J; Ploutz-Snyder R; Fernhall B
Am J Cardiol; 2016 Jul; 118(2):275-80. PubMed ID: 27241836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]